1 / 33

Radiology and Endocrinology

ANATOMY Radiography Ultrasound CT MRI. FUNCTION Radionuclide Imaging - Scintigraphy - PET. Radiology and Endocrinology. Radionuclide Imaging. Images metabolic pathways Pharmaceutical which mimics a component of a normal metabolic pathway is administered to the patient

edrennen
Download Presentation

Radiology and Endocrinology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ANATOMY Radiography Ultrasound CT MRI FUNCTION Radionuclide Imaging - Scintigraphy - PET Radiology and Endocrinology

  2. Radionuclide Imaging • Images metabolic pathways • Pharmaceutical which mimics a component of a normal metabolic pathway is administered to the patient • Pharmaceutical radiolabelled so that its distribution in the patient can be visualised with a gamma camera

  3. Ideal Radionuclide • emits gamma radiation at suitable energy for detection with a gamma camera (60 - 400 kev, ideal 150 kev) • should not emit alpha or beta radiation • half life similar to length of test • cheap • readily available

  4. Ideal radiopharmaceutical • cheap and readily available • radionuclide easily incorporated without altering biological behaviour • radiopharmaceutical easy to prepare • localises only in organ of interest • t1/2 of elimination from body similar to duration of test

  5. Thyroid - radiography • Little role • Thyroid mass diagnosed incidentally on chest radiograph • Thoracic inlet views may demonstrate tracheal compression

  6. Thyroid - ultrasound • High resolution (5 - 10 MHz) • Confirms - mass is thyroid cystic or solid single or multiple • cannot distinguish solid carcinoma from solid dominant nodule • Not useful in hyperthyroidism

  7. Thyroid - CT/MRI • Not as good as US at resolving lesions within the thyroid • Best tests for assessing mediastinal disease • CT better than MRI for calcification • MRI better than CT for distinguishing between fibrosis and residual tumour

  8. Thyroid - scintigraphy 99m PERTECHNETATE Trapped but not organified Competes with iodide for uptake Cheap and readily available IODINE (123I or 131 I) Trapped and organified Better for retrosternal goitres Expensive, cyclotron generated RECENT (10 days) IODINE CONTRAST BLOCKS UPTAKE

  9. Thyroid scintigraphy 99m Tc 123 NaI ADMIN iv po/iv PATIENT withdraw thyroid Rx PREP avoid high Iodine foods IMAGING 15 min pi 1-2hr pi 24 hr po

  10. Hyperthyroidism RN uptake 1. Thyroid gland (>95%) Toxic nodular goitre Diffuse toxic goitre (Graves) Thyroiditis 2. Exogenous T3/4/iodine Iatrogenic Iodine - induced (XRay contrast, amiodarone)

  11. Thyroid nodules Risk of malignancy Overall 10% US - cystic 0.3 - 10% US - solid ???? RNI - cold 16% RNI - hot 4% First line investigation: Cytology +/- US

  12. RNI in thyroid disease • Investigation of hyperthyroidism • Location of ectopic thyroid tissue (congenital hypothyroidism, retrosternal goitre) • Little role in thyroid nodules

  13. 1ry Hyperparathyroidism Type % Adenomas Single 80 Hyperplasia Chief cell 15 Clear cell 1 Carcinoma 4

  14. RN parathyroid imaging 99mTc / 201Tl 99mTc-MIBI subtraction scans early/late scans False positives: thyroid pathology False negatives: parathyroid hyperplasia Both good for ectopic parathyroids

  15. Parathyroid imaging • US not good at finding ectopic glands • CT Contrast Surgical artifacts • MRI Good for localisation and ectopic glands

  16. Imaging parathyroids Uncomplicated 1ry hyperparathyroidsim 90 -95% surgical success rate without imaging Recurrent/persistent hyperparathyroidism surgical success rate without imaging -50% with imaging - 90% (combined RNI + MRI)

  17. Adrenal glands Cortex aldosterone cortisol adrenal androgens Medulla adrenalin

  18. Adrenal glands • AXR - may show calcification • US - large masses only (unless neonatal) • CT - can detect small lesions - cannot distinguish metastases from non-functioning adenomas • MRI - small lesions - may distinguish mets from non-functioning adenomas

  19. Adrenal cortical RNI • Radiolabelled cholesterol esters (75 Seleno-methylnorcholesterol, 131 I - 6B iodomethyl-19-norcholesterol) • Image at 4 and 7 days • > 50% difference in activity between sides is abnormal

  20. RNI in Cushings syndrome ACTH-dependentCS bilat pituitary/ectopic ACTH -independent CS bilat nodular hyperplasia bilat adrenocortical adenoma uni Adrenocortical carcinoma bilat

  21. Cushings syndrome Diagnosis - biochemistry Localisation - CT/MRI for 1. Pituitary ACTH-dependent 2. Ectopic ACTH-dependant 3. ACTH - independant RNI not usually necessary

  22. RNI and Cushings syndrome Used for 1. Finding residual functioning adrenal remnants if recurrent disease after prior bilateral adrenalectomy 2. Somatostatin receptor scanning for ectopic ACTH from small bronchial carcinoid tumours

  23. Primary aldosteronism • small tumours may not be seen with CT/MRI • RNI + dexamethasone suppression can find tumours < 1cm • Adrenal visualisation before 5 days is abnormal (bilateral/unilateral)

  24. Adrenal medullary RNI Phaeochromocytoma Paraganglioma Neuroblastoma Ganglioneuroblastoma Ganglioneuroma

  25. Adrenal medullary RNI • Metaiodobenzylguanidine (MIBG) -localises in catecholamine storage vesicles of adrenergic nerve endings - 123 I or 131 I • somatostatin receptor imaging 111 In octreotide

  26. MIBG • phaeochromocytomas (95% sensitivity) • neuroblastoma (80 - 90% sens) • carcinoid • medullary thyroid carcinoma (MEN syndromes)

  27. Phaeochromocytomas 10% malignant bilateral extra- adrenal paediatric

  28. Phaeochromocytomas Diagnosis - biochemistry Localisation CT if > 2cm RNI to exclude - small tumours - bilateral adrenal - multifocal - metastases

  29. ‘Incidentalomas’ Incidental adrenal mass in patients undergoing abdominal imaging (2%) Q. Is it functioning? Is it benign or malignant?

  30. Functioning ‘incidentalomas’ Diagnosis Clinical features Biochmistry Confirmation RNI

  31. Non-functioning Non-functioning adenoma vs. metastasis • CT using attenuation values • MRI - chemical shift imaging

  32. Radiology and Endocrinology Localisation not Diagnosis

  33. IMAGINGand theENDOCRINE SYSTEM

More Related